All Stories

Trial results enhance Bristol Myers' bid for Sotyktu in psoriatic arthritis

At the American Academy of Dermatology's annual meeting this weekend, Bristol Myers Squibb revealed promising data from one of two successful trials of Sotyktu in psoriatic arthritis. The company added that will unveil results of the other trial by the end of this year.

Mar 10, 2025 - 14:14
 0
Trial results enhance Bristol Myers' bid for Sotyktu in psoriatic arthritis
At the American Academy of Dermatology's annual meeting this weekend, Bristol Myers Squibb revealed promising data from one of two successful trials of Sotyktu in psoriatic arthritis. The company added that will unveil results of the other trial by the end of this year.
Read More

Tags:

Previous Article

Sage Hospitality Group Launches Multimillion-Dollar Renovation of Denver’s The C...

Next Article

Chronic pain linked with depression, anxiety

Related Posts

Arbutus, Genevant expand COVID patent feud with Moderna with 5 international lawsuits

Arbutus, Genevant expand COVID patent feud with Moderna...

Mar 4, 2025  0

Merck KGaA's EMD Serono taps Selma Blair to join long-running campaign for MS drug Mavenclad

Merck KGaA's EMD Serono taps Selma Blair to join long-r...

Feb 20, 2025  0

After $2.2B Zantac settlement, GSK now faces investor lawsuit over the heartburn medication

After $2.2B Zantac settlement, GSK now faces investor l...

Feb 9, 2025  0